Schedule 13G ownership disclosure

Taysha Gene Therapies Inc

Common Stock, $0.00001 par value · CUSIP: 877619106

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Octagon Capital Advisors LP

    Shares: 10,450,000.00 · Class: 5.1%

  • Octagon Investments Master Fund

    Shares: 10,450,000.00 · Class: 5.1%

  • Ting Jia

    Shares: 10,450,000.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-002035
Form type
SCHEDULE 13G
Filer
Octagon Capital Advisors LP
CIK
CIK 1839435
Filed
Feb 05, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub